Biosurgery equipment sales will grow through 2036, led by bone graft substitute at 30.2% of the product type segment in 2026, driven by increasing clinical adoption and compliance requirements. The market was valued at USD 28.20 billion in 2025 and is expected to be worth USD 46.74 billion by 2036.